Clinical trial
Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of…
NCT00014274 · European Organisation for Research and Treatment of Cancer - EORTC, Other · Completed
Key facts
| NCT number | NCT00014274 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium |
| Official title | Randomized Phase II/III Study Assessing Gemcitabine/Carboplatin And Methotrexate/Carboplatin/Vinblastine In Previously Untreated Patients With Advanced Urothelial Cancer Ineligible For Cisplatin Based Chemotherapy |
| Lead sponsor | European Organisation for Research and Treatment of Cancer - EORTC, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Bladder Cancer, Transitional Cell Cancer of the Renal Pelvis and Ureter, Urethral Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, gemcitabine hydrochloride, methotrexate, vinblastine sulfate |
| Enrollment | 238 |
| Start date | Jan 1, 2001 |
| Primary completion | Mar 1, 2008 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 12, 2013 |
| Countries | Austria, Belgium, Denmark, Germany, Hungary, Israel, Italy, Netherlands, Poland, Spain, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: